The proportions of Haemophilus influenzae resistant to ampicillin and other -lactam antibiotics has been low in Scandinavia compared to other countries in the Western world. However, a near-doubled proportion of nasopharyngeal Swedish H. influenzae isolates with resistance to -lactams has been observed in the last decade. In the present study, the epidemiology and mechanisms of antimicrobial resistance of H. influenzae from blood and cerebrospinal fluid in Southern Sweden 1997-2010 (n=465) was studied. Antimicrobial susceptibility testing was performed with disk diffusion, and isolates with resistance to any tested -lactam were further analyzed in detail. We identified a significantly increased (p=0.03) proportion of -lactam resistant invasive H. influenzae during the study period, mainly attributed to a significant recent increase of -lactamase negative -lactam resistant isolates (p=0.04). Furthermore, invasive -lactamase negative -lactam resistant H. influenzae were from 2007 found in higher proportions than corresponding proportions of nasopharyngeal isolates in a national survey. Multiple locus sequence typing (MLST) of this group of isolates did not completely separate isolates with different resistance phenotypes. However, one cluster of -lactamase negative ampicillin resistant (BLNAR) isolates was identified, including isolates from all geographical areas. A truncated variant of a -lactamase gene, bla(TEM-1 P[del]) dominated among the lactamase positive H. influenzae isolates. Our results show that the proportions of betalactam-resistant invasive H. influenzae have increased in Sweden in the last decade.
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INTRODUCTION
Invasive disease by the respiratory pathogen Haemophilus influenzae has in the past been synonymous with disease by encapsulated type b (Hib), a cause of meningitis and epiglottitis in mainly children (6) . Following the introduction of the conjugated Hib vaccine in the early 1990s (introduced in the National Swedish Childhood Immunisation Schedule in 1992), a rapid decline in invasive Hib disease occurred (23) . Invasive disease by non-type b isolates of H. influenzae, including non-typeable Haemophilus influenzae (NTHi) and encapsulated serotypes other than Hib, has mainly been considered as opportunistic infections. In the last decade, however, a number of reports have indicated increasing incidences of invasive non-type b
Haemophilus disease that is not merely related to immunocompromised individuals (1, 3, 35) . A similar increase of invasive disease by non-type b H. influenzae in Sweden during the years 1997-2009 was recently confirmed by us (26) . Importantly, we found that both NTHi and Haemophilus influenzae type f (Hif) often cause severe sepsis in individuals with no evidence of immune suppression. More than 70% of bacteremic cases also had concurrent pneumonia (26) . From our study and others, it is evident that the epidemiology of invasive H. influenzae disease in general has changed.
Invasive H. influenzae disease mainly affected children in the the pre-Hib vaccine era, while now it affects both the very young and the very old, and cases are most commonly seen in older adults.
Resistance to ampicillin in H. influenzae was first described in 1974 (17) . Ampicillin is in Sweden, as in many other countries, the main drug of choice in proven H. influenzae infections and the primary empiric choice in respiratory tract infections, where H. influenzae can be suspected. Ampicillin resistance in H. influenzae is now globally widespread with incidences varying from 8-30% in different European countries and North America to more than 50% in some east Asian countries (12, 13) The nomenclature of resistant H. influenzae is complex, and since definitions vary between different studies and regions, the definitions used by us are outlined in Table   1 . Isolates with resistance to ampicillin can be sorted into two main categories; those that carry a -lactamase, and those that do not. The most common mechanism of lactam resistance in H. influenzae is by TEM-1 or ROB-1 -lactamases (7) , and such isolates are denoted "-lactamase positive ampicillin-resistant" (BLPAR). The commonly used term "-lactamase negative ampicillin resistant" (BLNAR) is used for isolates with ampicillin resistance with no evidence of -lactamase production.
After this definition was established, it was concluded that ampicillin resistance in such isolates was due to key mutations in the ftsI gene (encoding for penicillinbinding protein [PBP] 3) that lower the affinity for -lactams (36) . Subsequently, it became clear that some isolates had such mutations, but were not ampicillin resistant according to phenotype testing. Isolates with key mutations in PBP-3 regardless of resistance pheontype are designated as "genomic" BLNAR (gBLNAR), a group of isolates that overlaps, but does not match the BLNAR group (34, 36) .
Clinical isolates that are susceptible to ampicillin, but resistant to other -lactams are consequently not included in the BLNAR definition. However, other -lactam antibiotics than ampicillin are often used empirically in infections where H. influenzae can be the pathogen. Due to this, resistance of H. influenzae to other -lactam antibiotics than ampicillin needs to be considered. Since many years, the screening method for identification of -lactam resistant H. influenzae in Sweden has been disc diffusion tesing for penicillin and cefaclor/loracarbef followed by a nitrocefin resistanct -lactamase test. Even though penicillin rarely is an alternative for treatment of H. influenzae infections, experience suggests that this method is suitable for resistance surveillance, allowing for sensitive monitoring of -lactam resistance.
In this study we refer to the -lactamase negative isolates with resistance (according to disc diffusion test screening) to any tested -lactam antibiotic as "-lactamase negative -lactam resistant" (BLNBR). This term includes the BLNAR isolates as a subset. Finally, isolates with both a -lactamase and chromosomally derived resistance are defined as "-lactamase-positive amoxicillin-clavulanate resistant" (BLPACR).
The epidemiological trends of antimicrobial resistance in H. influenzae vary in different areas of the world. The proportions of -lactam resistant isolates in general, and specifically BLNARs are high in Japan and its neighboring countries, as demonstrated in several reports (10, 11, 28) . In Europe, reports are less consistent, where some reports suggest increasing proportions of isolates with ampicillin resistance (14, 32) , albeit at a lower level compared to Japan. In contrast, a recent Spanish report showed a decrease in proportions of ampicillin resistant strains (24) , demonstrating the local differences in resistance epidemiology. The proportion of - 
MATERIALS AND METHODS
Bacterial strains and culture conditions. The collection comprised clinical H. influenzae isolates from three densely populated regions in Sweden, i.e., Skåne County, Stockholm and Gothenburg. All isolates from blood and cerebrospinal fluid 1997-2010 (n=465) were registered, and available isolates (n=301) were stored at -70 °C. Bacteria were cultured on chocolate blood agar plates and incubated for 18 hrs at 35 C in a humid atmosphere containing 5% CO 2 .
DNA preparation and capsule typing by PCR.
In order to release bacterial DNA, 5 bacterial colonies were heated in sterile distilled water at 96°C for 10 mins. To amplify the capsule transport gene, a bexA-PCR was performed on all available strains (n=301) (5) . To further increase the sensitivity, all available strains were screened for bexB by PCR using the primers 5'-TTGTGCCTGTGCTGGAAGGTTATG-3' and 5'-GGTGATTAACGCGTTGCTTATGCG-3' (annealing temperature 54C), resulting in a product size of 567 bp. Strains positive for bexA and/or bexB were further tested for capsule type using specific primers against type b, a, d and f, c and e cap loci in sequential order (5) . Whenever a strain had previously been capsule typed by bex/cap PCR, the result was included in the analysis in case the strain was not available (n=21). Results from serotyping by agglutination with antisera were not used, since this method is considered inferior in specificity compared with PCR (29).
On all saved isolates from 1997-2009, a PCR to exclude the presence of H.
haemolyticus isolates was performed (21) . However, instead of a nested PCR, an initial PCR with primers denoted 16S3'and 16SNor was performed (26) . If a product of correct size was not obtained, isolates were subjected to 16SrRNA sequencing.
Since not a single isolate of H. haemolyticus was identified, the procedure was discontinued in 2010.
Antimicrobial susceptibility testing. The disk diffusion method was used for antimicrobial susceptibility testing (4) . Although not all strains were available for further analysis, all the clinical isolates were or had been tested for resistance to penicillin V, ampicillin, and trimethoprim-sulfamethoxazole. The majority of strains had been tested for resistance to tetracycline (95%), a cephalosporin (cefaclor/loracarbef and cefuroxime-axetil or cefotaxime) (98%), and a fluoroquinolone (nalidixic acid/ciprofloxacin/moxifloxacin or levofloxacin) (86%).
Only a few isolates had been tested for resistance to a carbapenem (imipenem/meropenem) (39%), chloramphenicol (6%), or an aminoglycoside (4%). 
Polymerase chain reaction (PCR) and sequencing for detection of bla(TEM) and
bla(ROB). All available -lactam resistant isolates that were tested positive for lactamase production were subjected to PCR to detect the specific -lactamase gene.
First, a bla(TEM-1) PCR was performed, and on TEM-1 PCR-negative isolates, a bla(ROB-1) PCR followed (30) . Since the bla(TEM-1) PCR resulted in products of two distinct sizes, DNA from representative isolates were sent for sequencing and compared to known bla(TEM-1) variants (20, 34) . The sequenced isolates were included as controls in the bla(TEM-1) PCR.
PBP-3 sequencing. All available isolates that were either defined as BLNBR ("lactamase negative -lactam resistant") or BLPACR ("-lactamase positive amoxicillin-clavulanate resistant") using the method described above were subjected to an ftsI-PCR, amplifying the transmembranous part of PBP-3 using primers 5'- 
RESULTS

Increasing numbers and proportions of invasive betalactam-resistant H.
influenzae in Sweden 1997-2010. We recently observed an increase of invasive H.
influenzae disease in Sweden 1997-2009 (26) that was in parallel with similar epidemiological findings in North America as well as in Europe (18, 35) . In the present study, results from 2010 were also included. Since 2010 holds the highest incidence per 100,000 individuals during the study period, a continued increasing incidence trend is suggested (Fig. 1A) . The increase was dominated by NTHi. We also studied the susceptibility patterns for other antimicrobial agents. The proportion of isolates resistant to trimethoprim-sulfamethoxazole varied from 6-20%
per year, and no trend suggesting increasing incidences was seen throughout the study period. This contrasts to the national nasopharyngeal surveillance, where an increasing trend of resistance to the folic acid antagonists has been observed (http://www.smi.se/upload/stat/haemophilus-influenzae-99-09.gif). Finally, resistance to fluoroquinolones and tetracycline remained low during the study period; 2.1% and 1.9%, respectively.
The gene variant bla(TEM-1P[del]) dominates among BLPAR isolates. All
identified ß-lactamase positive isolates (BLPAR or BLPACR) ( Table 1 ) that were available for further analysis (n=33) were resistant to ampicillin (the MIC for ampicillin ranged from 4 to 256 mg/L). The corresponding -lactamase gene was defined by PCR in 30 out of 33 isolates, and we found that bla(TEM-1) dominated (n=29). Only one isolate carrying the bla(ROB-1) gene was found. The gene product encoding for TEM-1 was detected in two variants, resulting in different DNA products using the same primer pair ( Fig. 2A) . After sequencing, it was clear that the gene, whereas 11 isolates carried the wild-type bla(TEM-1)). The median MIC for ampicillin, however, was the same for the two identified bla(TEM) gene variants.
Finally, we found three -lactamase positive (as revealed by nitrocephine testing)
ampicillin-resistant H. influenzae isolates from 2009 and 2010 that were negative for both bla(TEM) and bla(ROB) genes using the described primers. Table 2 , we show all variants of PBP-3 that was identified among the BLNBR isolates and the correlating MIC ranges for ampicillin. Genotype II dominated among BLNAR isolates, and a correlation between the BLNAR genotypes and ampicillin resistance phenotype was confirmed.
However, several isolates that were resistant to other -lactams but susceptible to ampicillin did not have BLNAR-defining substitutions in PBP-3. Seven BLNBR isolates did not have any mutations at all in PBP-3. This result implies that other mechanisms than -lactamase production and substitutions in PBP-3 contribute to - In the resulting neighbor-joining analysis, clusters supported by bootstrap values of >70% were considered well supported (indicated in Fig. 2C ). The phylogenetic analysis identified several clusters with bootstrap support of 70% or more, where one cluster contained 7 BLNAR isolates (indicated in Fig 2C) . Interestingly, this BLNAR cluster comprised isolates from all three distinct geographical areas in the study, all from the period 2008-2010. Furthermore, all of the isolates in the cluster had identical PBP-3 sequences, belonging to genotype IIb according to the classification by Dabernat and colleagues (2) . Even though the numbers are small, these findings together suggest a clonal spread of this particular cluster.
DISCUSSION
This study identifies an increase in proportions of -lactam resistance among invasive H. influenzae isolates in Sweden during the years 1997-2010. The proportions of lactam resistant isolates reached 30% in the final years of the study period. The observed increase was not mainly due to an increase of -lactamase producing isolates, but among these a bla(TEM-1) variant with a promotor deletion dominated (i.e., bla(TEM -1P[del] )). The increase was mainly due to a recent rise in -lactamase negative -lactam resistant (BLNBR) isolates. Since such isolates have a potential for resistance to multiple antibiotics (34), the observation is of concern. Not all of the BLNBR isolates displayed true BLNAR phenotypes, but most isolates were resistant to multiple -lactam antibiotics. Our study also confirms a strong, but not perfect correlation between BLNAR-defining amino acid substitutions and the ampicillin resistance phenotype established in earlier studies (2, 9, 31, 36) . However, it is evident that other mechanisms than PBP-3 mutations or -lactamase production contribute to -lactam resistance in H. influenzae. A few such mechanisms, including disrupted repression of the acrR efflux pump, have been suggested (15) .
Since the study outline is retrospective, our study has limitations. Not all isolates were available for detailed study, and since the absolute numbers of H. influenzae were limited, the statistical calculations as well as the indications from the MLST analysis should be interpreted with caution. Furthermore, the reliability of the disk diffusion method for defining precise levels of betalactam-resistance in H. influenzae has been questioned. However, as a primary screening method for resistance in clinical isolates, followed by a detailed examination, the disk diffusion method was considered suitable. Previous reports that have studied clonal relations of resistant H. influenzae have used PFGE (9, 32) , and PFGE is a common method for studying clonal relations in local outbreaks with a limited geographical distribution. Even though all methods have limitations, we believe that MLST is advantageous with its benefits of a high resolution power and the possibility of international comparisons.
Acquisition of antimicrobial resistance is often thought to imply a fitness cost and thereby theoretically reduce bacterial fitness and virulence. However, evidence points to that antimicrobial resistance in Gram-negative bacteria can be linked to a higher degree of virulence (27) , possibly due to co-carriage of resistance and virulence genes. The explanation for the increase of the proportion of resistant invasive H.
influenzae isolates is likely to be multifactorial. Selection pressure from liberal use of antibiotics on upper airway infections can be a contributing factor, and there is support for this mechanism in earlier reports (8) . Moreover, a contribution of the spread of dominant clones of H. influenzae with antimicrobial resistance should be considered. Such patterns have been suggested in earlier studies (12, 16) . The MLST results from the present study of invasive isolates suggests a spread of one BLNAR clone with close genetic relation, but the absolute number of isolates was too small to fully conclude this as a fact. Two observations strengthening this indication is that the cluster comprised of isolates from all three geographical areas of the study, and all of the isolates of this cluster had identical PBP-3 sequences. Among the BLPAR isolates, the reason for the spread and domination of the bla(TEM-1 P[del]) variant needs further investigation.
The finding of higher proportions of -lactamase negative -lactam resistant H.
influenzae invasive isolates, including BLNAR, than in the surveillance of nasopharyngeal disease carriage strains is intriguing. Since not all isolates were tested for cephalosporines or carbapenems, and since all were not available for PBPsequencing, the numbers in this group may be an actual underestimate. The possibility of a higher invasive capacity of resistant strains cannot be excluded, and such suggestions have been made for BLNAR isolates in earlier work (22) . Since the study is skewed towards metropolitan areas of Sweden, however, the risk of the results reflecting local Swedish differences in resistance epidemiology also has to be considered. Interestingly, when the BLNBR dataset was statistically examined, the curve was fitted almost equally well with a cubic equation as the quadratic one used in the analysis. One may argue that a cubic equation, with a reduction in the rate of increase at the end of the study period may be a more plausible estimate, but the following years will show which model predicts future incidences the best.
To assess the relevance of studying H. influenzae resistance to all -lactams, and not only to ampicillin, in a clinical setting, we registered the initial antibiotic given to the patients in 106 cases of H. influenzae sepsis in the county of Skåne (data not shown).
The majority (53%) were primarily given a second-or third-generation cephalosporin.
Interestingly, 28% were given benzylpenicillin, 15% were given a carbapenem, and only one single patient was administered ampicillin as a starting antibiotic. This observed empirical treatment strategy reflects the clinical need to consider resistance of H. influenzae to also other -lactams than ampicillin, most noteably cephalosporins and penicillins. Resistance to ampicillin or penicillin and a tested cephalosporin using SRGA breakpoints.
Nitrocephine positive.
3 1 All studied isolates that were nitrocephine positive had MIC for ampicillin ≥ 2 mg/L. 2 Swedish Reference Group for Antibiotics. 3 Numbers are out of 465 tested isolates, but since only a portion of isolates were available for E-test and sequencing, the number of BLNAR and gBLNAR are defined from fewer isolates, and are not comparable to the other numbers. 4 Penicillin binding protein 3. 
